FrancophonIA/ELRC3.0 huggingface dataset:
English: Metabolic interactions are not considered likely, since ibandronic acid does not inhibit the major human hepatic P450 isoenzymes and has been shown not to induce the hepatic cytochrome P450 system in rats (see section 5.2).
Croatian: Pojava metaboličkih interakcija nije vjerojatna jer ibandronatna kiselina ne inhibira glavne humane jetrene izoenzime P450 i ne inducira jetreni citokromatski P450 sustav u štakora (vidjeti dio 5.2).
English: Children and adolescents Ibandronic acid Accord should not be used in children and adolescents below the age of 18 years.
Croatian: Djeca i adolescenti Ibandronic acid Accord se ne smije davati djeci i adolescentima mlađim od 18 godina.
English: No dose adjustment is necessary for patients with mild or moderate renal impairment where serum creatinine is equal or below 200 μmol/l (2.3 mg/dl) or where creatinine clearance (measured or estimated) is equal or greater than 30 ml/min.
Croatian: Nije potrebna prilagodba doze u bolesnika s blagim ili umjerenim oštećenjem funkcije bubrega u kojih je kreatinin u serumu jednak ili manji od 200 μmol/l (2,3 mg/dl) ili u kojih je klirens kreatinina (mjeren ili procijenjen) jednak ili veći od 30 ml/min.
English: Appropriate medical support and monitoring measures should be readily available when ibandronic acid intravenous injection is administered.
Croatian: Odgovarajuća liječnička podrška i mjere praćenja trebaju biti lako dostupne tijekom intravenske primjene ibandronatne kiseline.
English: Where the medicinal product is administered into an existing intravenous infusion line, the infusate should be restricted to either isotonic saline or 50 mg/ml (5 %) glucose solution.
Croatian: Kad se lijek primjenjuje u postojeći intravenski infuzijski put, infuzijska otopina mora biti ograničena na izotoničnu otopinu natrijeva klorida ili 50 mg/ml (5%) otopinu glukoze.
English: Ibandronic acid is only for use in postmenopausal women and must not be taken by women of child bearing potential.
Croatian: Ibandronatna kiselina je namijenjena isključivo za žene u postmenopauzi i ne smiju je primjenjivati žene reproduktivne dobi.
English: For lumbar spine BMD, 92.1 % of patients receiving 3 mg injection every 3 months increased or maintained their BMD after 1 year of treatment (i.e. were responders) compared with 84.9 % of patients receiving oral 2.5 mg daily (p=0.002).
Croatian: BMD lumbalne kralježnice u 92,1% bolesnika koji primaju injekciju od 3 mg svaka tri mjeseca povećala se ili ostala ista nakon jednogodišnjeg liječenja (bolesnici koji su odgovorili na liječenje) u usporedbi s 84,9% bolesnika koji su peroralno primali 2,5 mg jedanput dnevno (p=0,002).
English: Other adverse reactions to ibandronic acid in reproductive toxicity studies in the rat were those observed with bisphosphonates as a class.
Croatian: Ostale nuspojave ibandronatne kiseline opažene u ispitivanjima reproduktivne toksičnosti u štakora jednake su očekivanima za bisfosfonate kao skupinu lijekova.
English: What Ibandronic acid Accord contains
Croatian: Što Ibandronic acid Accord sadrži
English: Ibandronic acid Accord 3 mg solutionfor injection (for osteoporosos indications) Medicinal product subject to medical prescription.
Croatian: Ibandronic acid Accord 3 mg otopina za injekciju (za indikacije osteoporoze) Lijek se izdaje na recept.
English: This medicine contains less than 1 mmol sodium (23 mg) per dose (3 ml), i.e. ‘essentially sodiumfree'.
Croatian: Ovaj lijek sadrži manje od 1 mmol natrija (23 mg) po dozi (3 ml), odnosno zanemarive količine natrija.
English: Ibandronic acid 2.5 mg daily tablets
Croatian: Ibandronatna kiselina 2,5 mg tablete jedanput dnevno
English: See also dose section above for patients with renal impairment.
Croatian: Pogledajte i poglavlje iznad o doziranju u bolesnika s oštećenjem bubrega.
English: Patients with cardiac impairment
Croatian: Bolesnici s oštećenjem srca
English: After intravenous administration of 0.5 mg of ibandronic acid, total, renal, and non-renal clearances decreased by 67 %, 77 % and 50 %, respectively, in subjects with severe renal failure, but there was no reduction in tolerability associated with the increase in exposure.
Croatian: Nakon intravenske primjene 0,5 mg ibandronatne kiseline u bolesnika sa teškim oštećenjem funkcije bubrega, ukupni, bubrežni i nebubrežni klirens smanjili su se za 67%, 77% odnosno 50%.
English: After 2 years of treatment, 85.6 % of patients receiving 3 mg injections and 77.0 % of patient receiving 2.5 mg oral therapy had increased or maintained total hip BMD (p=0.004).
Croatian: Nakon dvogodišnjeg liječenja 85,6% bolesnika koji su primali injekcije od 3 mg i 77,0% bolesnika koji su primali peroralno liječenje od 2,5 mg imalo je povećanu ili nepromijenjenu BMD cijelog kuka (p=0,004).
English: Where Ibandronic acid Accord is administered via an existing intravenous infusion line, the intravenous infusate should be restricted to either isotonic saline or 50 mg/ml (5 %) glucose solution.
Croatian: Kada se Ibandronic acid Accord primjenjuje putem postojećeg intravenskog infuzijskog puta, infuzijska otopina mora biti ograničena na izotoničnu otopinu natrijeva klorida ili 50 mg/ml (5%) otopinu glukoze.
English: Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe like other bisphosphonates administered intravenously, may cause a transient decrease in serum calcium values.
Croatian: Ibandronic acid Accord 3 mg otopina za injekciju u napunjenoj štrcaljki može, poput ostalih bisfosfonata koji se primjenjuju intravenski, izazvati prolazno smanjenje vrijednosti kalcija u serumu.
English: For this purpose the contents of the vial are to be used as follows: - Prevention of Skeletal Events in patients with breast cancer and bone metastases - added to 100 ml isotonic sodium chloride solution or 100 ml 5 % dextrose solution and infused over at least 15 minutes.
Croatian: Da bi se primijenio, sadržaj bočice treba koristiti na sljedeći način: sprječavanje koštanih poremećaja u bolesnika s rakom dojke i koštanim metastazama - treba ga dodati u 100 ml izotonične otopine natrijevog klorida ili u 100 ml 5%-tne otopine glukoze i primijeniti infuzijom u trajanju od najmanje 15 minuta.
English: What you need to know before you receive Ibandronic acid Accord
Croatian: Što morate znati prije nego počnete primjenjivati Ibandronic acid Accord
English: Children and adolescents Ibandronic acid Accord must not be used in children or adolescents below 18 years.
Croatian: Djeca i adolescenti Ibandronic acid Accord se ne smije davati djeci ni adolescentima mlađima od 18 godina.
English: Hypocalcaemia and other disturbances of bone and mineral metabolism should be assessed and effectively treated before starting Ibandronic acid Accord injection therapy.
Croatian: Hipokalcijemiju i ostale poremećaje metabolizma kostiju i minerala potrebno je procijeniti i učinkovito liječiti prije početka terapije injekcijama lijeka Ibandronic acid Accord.
English: Uncommon Rare
Croatian: Vrlo rijetko Nepoznat o
English: After 2 years of treatment, 92.8 % of patients receiving 3 mg injections and 84.7 % of patient receiving 2.5 mg oral therapy had increased or maintained lumbar spine BMD (p=0.001).
Croatian: Nakon dvogodišnjeg liječenja 92,8% bolesnika koji su primali injekcije od 3 mg te 84,7% bolesnika koji su primali peroralno liječenje od 2,5 mg imalo je povećanu ili nepromijenjenu BMD lumbalne kralježnice (p=0,001).
English: Discontinuation of bisphosphonate therapy in patients suspected to have an atypical femur fracture should be considered pending evaluation of the patient, based on an individual benefit risk assessment.
Croatian: U bolesnika kod kojih se sumnja na atipičan prijelom bedrene kosti treba razmotriti obustavljanje liječenja bisfosfonatima nakon procjeni stanja bolesnika i na temelju ocjene omjera koristi i rizika za svakoga pojedinog bolesnika.
English: • stomach pain (such as gastritis) or tummy pain, , indigestion, nausea, having diarrhoea (loose bowels) or constipation
Croatian: • bol u želucu (poput gastritisa) ili bol u trbuhu, probavne smetnje, mučnina, proljev (osjetljiva crijeva) ili zatvor
English: Each pre-filled syringe contains 3 ml of solution.
Croatian: Jedna napunjena štrcaljka sadrži 3 ml otopine.
English: Administration of Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe Ibandronic acid Accord 3 mg solution for injection in pre-filled syringe should be injected intravenously over a period of 15 - 30 seconds.
Croatian: Primjena Ibandronic acid Accord 3 mg otopine za injekciju u napunjenoj štrcaljki Ibandronic acid Accord 3 mg otopina za injekciju u napunjenoj štrcaljki injicira se intravenski u trajanju od 15 do 30 sekundi.
English: • Treatment of tumour-induced hypercalcaemia - added to 500 ml isotonic sodium chloride solution or 500 ml 5% dextrose solution and infused over 2 hours.
Croatian: • liječenje hiperkalcijemije nastale zbog tumora - treba ga dodati u 500 ml izotonične otopine natrijevog klorida ili 500 ml 5%-tne otopine glukoze i primijeniti infuzijom u trajanju od 2 sata.
English: All patients must receive supplemental calcium and vitamin D.
Croatian: Svi bolesnici moraju primiti dodatne količine kalcija i vitamina D.
English: Clinical studies in the treatment of tumour-induced hypercalcaemia
Croatian: Klinička ispitivanja u liječenju hiperkalcijemije nastale zbog tumora
English: Each ml of solution contains 1 mg ibandronic acid.
Croatian: Jedan ml otopine sadrži 1 mg ibandronatne kiseline.
English: For total hip BMD, 82.3 % of patients receiving 3 mg injection every 3 months were responders at one year, compared with 75.1 % of patients receiving 2.5 mg daily orally (p=0.02).
Croatian: Što se tiče vrijednosti BMD cijelog kuka, 82,3% bolesnika koji su primali injekciju od 3 mg svaka tri mjeseca, odgovorili su na liječenje nakon jedne godine, u usporedbi s 75,1% bolesnika koji su primali peroralnu dozu od 2,5 mg jedanput dnevno (p=0,02).
English: Clinical studies in the prevention of skeletal events in patients with breast cancer and bone metastases
Croatian: Klinička ispitivanja prevencije koštanih poremećaja u bolesnika s rakom dojke i koštanim metastazama
English: 6 ml, glass vial (type I) with ethylene tetrafluoroethylene rubber stopper and aluminium seals with pink flip-off cap.
Croatian: Staklena bočica od 6 ml (staklo tip I), s etilen tetrafluoroetilenskim gumenim čepom i aluminijskim prstenom s „flip-off“ kapicom ružičaste boje.
English: Other medicines and Ibandronic Acid Accord
Croatian: Drugi lijekovi i Ibandronic acid Accord
English: Sleep disorder, anxiety, affection lability
Croatian: Psihijatrijski poremećaji poremećaj spavanja, anksioznost, afektivna labilnost
English: Prescribers should consult the section Patients with Renal Impairment below for recommendations on dosing and administration in this patient group.
Croatian: Propisivači mogu pronaći preporuke za doziranje i primjenu u toj skupini bolesnika u odjeljku Bolesnici s oštećenjem bubrega u nastavku.
English: dosing regimen, there was no evidence for a direct foetal toxic or teratogenic effect of ibandronic acid in rats and rabbits.
Croatian: U ispitivanjima primjene svakodnevne intravenske doze nije bilo dokaza izravne toksičnosti za plod ili teratogenih učinaka ibandronatne kiseline u zečeva i štakora.
English: Ibandronic acid concentrate for solution for infusion should be administered as an intravenous infusion over 2 hours.
Croatian: Koncentrat ibandronatne kiseline za otopinu za infuziju treba primijeniti kao intravensku infuziju u trajanju od 2 sata.
English: Up to now there is no experience of acute poisoning with Ibandronic acid Accord concentrate for solution for infusion.
Croatian: Do sada nije bilo slučajeva akutnog trovanja Ibandronic acid Accord koncentratom za otopinu za infuziju.
English: 6 ml, glass vial (type I) with ethylene tetrafluoroethylene rubber stopper and aluminium seals with lavender flip-off cap.
Croatian: Staklena bočica od 6 ml (staklo tip I), s etilen tetrafluoroetilenskim gumenim čepom i aluminijskim prstenom s „flip-off“ kapicom boje lavande.
English: Gastritis, Dyspepsia, Diarrhoea, Abdominal pain, Nausea, Constipation
Croatian: Poremećaji probavnog sustava gastritis, dispepsija, proljev, bol u abdomenu, mučnina, konstipacija
English: All patients must receive adequate supplemental calcium and vitamin D.
Croatian: Svi bolesnici moraju primiti odgovarajuće dodatne količine kalcija i vitamina D.
English: Ibandronic acid 3 mg injection every 3 months Bone mineral density (BMD)
Croatian: Injekcija ibandronatne kiseline od 3 mg svaka tri mjeseca Mineralna gustoća kosti (BMD - Bone mineral density)
English: Other disturbances of bone and mineral metabolism should also be effectively treated before starting ibandronic acid injection therapy.
Croatian: Ostale poremećaje metabolizma kostiju i minerala također se mora učinkovito liječiti prije početka terapije injekcijama ibandronatne kiseline.
English: • kidney cyst(fluid-filled sac in the kidney)
Croatian: • bubrežna cista (vrećica u bubregu ispunjena tekućinom)
English: No specific information is available on the treatment of overdosage with ibandronic acid injection.
Croatian: Nisu dostupne specifične informacije o liječenju u slučajevima predoziranja injekcijom ibandronatne kiseline.
English: Calcium containing solutions should not be mixed with Ibandronic acid Accord concentrate for solution for infusion.
Croatian: Otopine koje sadrže kalcij ne smiju se miješati s Ibandronic acid Accord koncentratom za otopinu za infuziju.
English: Osteonecrosis of the jaw (ONJ) has been reported very rarely in the post marketing setting in patients receiving ibandronic acid for oncology indications (see section 4.8).
Croatian: Osteonekroza čeljusti primijećena je vrlo rijetko nakon stavljanja lijeka u promet u bolesnika koji su primali ibandronatnu kiselinu za onkološke indikacije (vidjeti dio 4.8).
English: In order to avoid potential incompatibilities, Ibandronic acid Accord concentrate for solution for infusion should only be mixed with isotonic sodium chloride solution or with 5% dextrose solution.
Croatian: Da bi se izbjegle potencijalne inkompatibilnosti, Ibandronic acid Accord koncentrat za otopinu za infuziju smije se miješati samo izotoničnom otopinom natrijevog klorida ili 5%-tnom otopinom glukoze.
English: Patients treated with ibandronic acid should be given the package leaflet and the patient reminder card. Posology
Croatian: Bolesnicima koji se liječe ibandronatnom kiselinom treba dati uputu o lijeku i karticu s podsjetnicima za bolesnika.
English: See also dosage section above for patients with renal impairment - Treatment of tumour-induced hypercalcaemia - added to 500 ml isotonic sodium chloride solution or 500 ml 5% dextrose solution and infused over 2 hours
Croatian: Pogledajte i poglavlje iznad o doziranju u bolesnika s oštećenjem bubrega. liječenje hiperkalcijemije nastale zbog tumora - treba ga dodati u 500 ml izotonične otopine natrijevog klorida ili u 500 ml 5%-tne otopine glukoze te primijeniti infuzijom u trajanju od 2 sata.
English: To avoid potential incompatibilities Ibandronic acid concentrate for solution for infusion should only be diluted with isotonic sodium chloride solution or 5% glucose solution.
Croatian: Da bi se izbjegle potencijalne inkompatibilnosti, Ibandronic acid koncentrat za otopinu za infuziju smije se razrijediti samo izotoničnom otopinom natrijevog klorida ili 5%-tnom otopinom glukoze.
English: Incidence of new morphometric vertebral fractures
Croatian: Incidencija novih prijeloma kralježaka, utvrđeni morfometrički
English: ibandronic acid 3 mg injection every 3 months (N=365)
Croatian: Injekcija ibandronatne kiseline od 3 mg svaka 3 mjeseca (N=365)
English: Talk to your doctor first if you want to drive, use machines or tools.
Croatian: Ukoliko želite voziti, koristiti strojeve ili alate, posavjetujte se najprije sa svojim liječnikom.
English: Metabolism and nutrition disorders
Croatian: Poremećaj metabolizma i prehrane hipokalcijemija*
English: What Ibandronic acid Accord looks like and contents of the pack Ibandronic acid Accord 3 mg solution for injection in pre-filled syringes is a clear colourless solution.
Croatian: Kako Ibandronic acid Accord izgleda i sadržaj pakiranja Ibandronic acid Accord 3 mg otopina za injekciju u napunjenoj štrcaljki bistra je i bezbojna otopina.
English: Blood and lymphatic system disorders
Croatian: Poremećaji krvi i limfnog sustava anemija, krvna diskrazija
English: Phlebitis/ thrombophlebitis
Croatian: Krvožilni poremećaji flebitis/tromboflebitis
English: The median time to relapse (return of albumin-corrected serum calcium to levels above 3 mmol/l) was 18-19 days for the 2 mg and 4 mg doses.
Croatian: Medijan vremena do pojave recidiva (povratka vrijednosti kalcija u serumu korigiranih albuminom na razinu višu od 3 mmol/l) iznosio je 18 - 19 dana za doze od 2 mg i 4 mg.
English: The proportion of patients who increased or maintained their BMD at one year at both lumbar spine and total hip was 76.2 % in the 3 mg injection every 3 months arm and 67.2 % in the 2.5 mg daily orally arm (p=0.007).
Croatian: Udio bolesnika koji je imao povećanu ili nepromijenjenu BMD lumbalne kralježnice i cijelog kuka nakon jedne godine iznosio je 76,2% u bolesnika koji su primali injekciju od 3 mg svaka tri mjeseca te 67,2% u bolesnika koji su primali peroralno liječenje od 2,5 mg jedanput dnevno (p=0,007).
English: For patients with mild renal impairment (CLcr ≥50 and <80 ml/min) no dosage adjustment is necessary.
Croatian: Za bolesnike s blagim oštećenjem bubrega (Clcr ≥50 i <80 ml/min) nije potrebna prilagodba doze.
English: A side effect called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported very rarely in the post marketing setting in patients receiving ibandronic acid for cancer-related conditions.
Croatian: Nuspojava koja se zove ostenekroza čeljusti (oštećenje kosti vilice) zabilježena je vrlo rijetko nakon stavljanja lijeka u promet u bolesnika koji su primali ibandronatnu kiselinu za zdravstvena stanja povezana s rakom.
English: ibandronic acid 3 mg injection every 3 months (N=334)
Croatian: Injekcija ibandronatne kiseline od 3 mg svaka 3 mjeseca (N=334)
English: Hypocalcaemia
Croatian: hipokalcijemija
English: (N=974)
Croatian: Placebo (n=974)
English: Osteonecrosis of the jaw (ONJ) has been reported very rarely in the post marketing setting in patients receiving ibandronic acid for osteoporosis (see section 4.8).
Croatian: Osteonekroza čeljusti primijećena je vrlo rijetko nakon stavljanja lijeka u promet u bolesnika koji su primali ibandronatnu kiselinu za osteoporozu (vidjeti dio 4.8).
English: Hypocalcaemia and other disturbances of bone and mineral metabolism should be effectively treated before starting ibandronic acid therapy for metastatic bone disease.
Croatian: Hipokalcijemiju i ostale poremećaje metabolizma kostiju i minerala potrebno je učinkovito izliječiti prije početka liječenja metastatske bolesti kostiju ibandronatnom kiselinom.
English: • persistent eye pain and inflammation (if prolonged)
Croatian: • bol u oku ili upala oka koji ne prestaju (ako traju dulje)
English: • being unable to pass water (urine), cystitis (bladder inflammation)
Croatian: • poteškoće s mokrenjem, cistitis (upala mokraćnog mjehura)
English: Ibandronic acid solution for injection must not be mixed with calcium-containing solutions or other intravenously administered medicinal products.
Croatian: Otopina ibandronatne kiseline za injekciju ne smije se miješati s otopinama koje sadrže kalcij kao ni s drugim lijekovima za intravensku primjenu.
English: Ibandronic acid Accord contains sodium
Croatian: Ibandronic acid Accord sadrži natrij
English: Ibandronic acid Accord contains the active substance ibandronic acid.
Croatian: Ibandronic acid Accord sadrži djelatnu tvar, ibandronatnu kiselinu.
English: Solution for injection 1 pre-filled syringe + 1 injection needle 4 pre-filled syringes + 4 injection needles
Croatian: 4 napunjene štrcaljke + 4 injekcijske igle
English: Table 1 Adverse Reactions Reported for Intravenous Administration of Ibandronic Acid
Croatian: Tablica 1 Nuspojave lijeka prijavljene kod intravenske primjene ibandronatne kiseline Klasifikacija organskih sustava
English: One vial with 6 ml concentrate for solution for infusion contains 6 mg ibandronic acid (as sodium monohydrate).
Croatian: Jedna bočica sa 6 ml koncentrata za otopinu za infuziju sadrži 6 mg ibandronatne kiseline (u obliku natrijevog ibandronat hidrata).
English: Overdose No specific information is available on the treatment of overdosage with Ibandronic acid Accord.
Croatian: Nisu dostupni specifični podaci o liječenju u slučajevima predoziranja lijekom Ibandronic acid Accord.
English: Due to the limited clinical experience, ibandronic acid is not recommended in patients with severe renal impairment (see section 4.2 and section 4.4).
Croatian: Ibandronatna kiselina se ne preporučuje bolesnicima s teškim oštećenjem funkcije bubrega zbog ograničenih kliničkih iskustava (vidjeti poglavlja 4.2 i 4.4).
English: EU/1/12/798/002 EU/1/12/798/003 EU/1/12/798/004
Croatian: EU/1/12/798/001 EU/1/12/798/002 EU/1/12/798/003 EU/1/12/798/004
English: It is supplied in glass vials (type I) with rubber stopper and aluminium seals with flip-off cap.
Croatian: Dostupna je u staklenim bočicama (staklo tipa I) s gumenim čepom i aluminijskim prstenom s „flipoff“ kapicom.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One vial with 2 ml concentrate for solution for infusion contains 2 mg ibandronic acid (as sodium monohydrate).
Croatian: 2. KVALITATIVNI I KVANTITATIVNI SASTAV Jedna bočica s 2 ml koncentrata za otopinu za infuziju sadrži 2 mg ibandronatne kiseline (u obliku natrijevog ibandronat hidrata).
English: Ibandronic acid was not studied in the paediatric population, therefore no efficacy or safety data are available for this patient population.
Croatian: Pedijatrijska populacija (vidjeti dijelove 4.2 i 5.2) Ibandronatna kiselina nije ispitivana na pedijatrijskoj populaciji, stoga nisu dostupni podaci o djelotvornosti i sigurnosti primjene u ovoj skupini bolesnika.
English: A 15 minute infusion time has not been studied in cancer patients with CLcr <50 ml/min.
Croatian: Nije provedeno ispitivanje 15-minutne infuzije u bolesnika oboljelih od raka s Clcr <50 ml/min.
English: A 15 minute infusion time has not been studied in cancer patients with CLCr <50 ml/min.
Croatian: Nije provedeno ispitivanje 15-minutne infuzije u bolesnika oboljelih od raka s CLCr <50 ml/min.
English: Osteonecrosis of the external auditory canal (bisphosphonate class adverse reaction)†
Croatian: osteonekroza čeljusti†** osteonekroza vanjskog slušnog hodnika (nuspojava bisfosfonata)†
English: If you have any further questions on the use of this medicine, ask your doctor, or pharmacist or nurse.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se liječniku, ljekarniku ili medicinskoj sestri.
English: At two years, 80.1 % and 68.8 % of patients met this criterion in the 3 mg every 3 months injection arm and the 2.5 mg daily arm (p=0.001).
Croatian: Nakon dvije godine taj je kriterij zadovoljilo 80,1% bolesnika koji su primali injekciju od 3 mg svaka tri mjeseca odnosno 68,8% bolesnika koji su primali 2,5 mg jedanput dnevno (p=0,001).
English: Up to now there is no experience of acute poisoning with ibandronic acid concentrate for solution for infusion.
Croatian: Do sada nije bilo slučajeva akutnog trovanja koncentratom ibandronatne kiseline za otopinu za infuziju.
English: Sodium chloride, sodium acetate trihydrate, glacial acetic acid and water for injections.
Croatian: Natrijev klorid, natrijev acetat trihidrat, ledena acetatna kiselina i voda za injekcije.
English: Blood alkaline phosphatase increase, weight decrease
Croatian: Pretrage povišena razina gama-GT-a, povišena razina kreatinina povećanje alkalne fosfataze u krvi, smanjenje tjelesne težine